Research & Development World

  • R&D World Home
  • Topics
    • Aerospace
    • Automotive
    • Biotech
    • Careers
    • Chemistry
    • Environment
    • Energy
    • Life Science
    • Material Science
    • R&D Management
    • Physics
  • Technology
    • 3D Printing
    • A.I./Robotics
    • Software
    • Battery Technology
    • Controlled Environments
      • Cleanrooms
      • Graphene
      • Lasers
      • Regulations/Standards
      • Sensors
    • Imaging
    • Nanotechnology
    • Scientific Computing
      • Big Data
      • HPC/Supercomputing
      • Informatics
      • Security
    • Semiconductors
  • R&D Market Pulse
  • R&D 100
    • 2025 R&D 100 Award Winners
    • 2025 Professional Award Winners
    • 2025 Special Recognition Winners
    • R&D 100 Awards Event
    • R&D 100 Submissions
    • Winner Archive
  • Resources
    • Research Reports
    • Digital Issues
    • Educational Assets
    • R&D Index
    • Subscribe
    • Video
    • Webinars
    • Content submission guidelines for R&D World
  • Global Funding Forecast
  • Top Labs
  • Advertise
  • SUBSCRIBE

Doctor behind “free radical” aging theory dies

By R&D Editors | November 25, 2014

 
              In this photo taken on Feb. 14, 2006, Dr. Denham Harman smiles at his 90th birthday celebration at the University of Nebraska Medical Center in Omaha, Neb. Harman, the scientist who developed the most widely accepted theory on aging that's used study cancer and other diseases died Tuesday, Nov. 25, 2014, at 98.  Harman developed the

Dr. Denham Harman, a renowned scientist who developed the most widely accepted theory on aging that’s now used to study cancer, Alzheimer’s disease and other illnesses, has died in Nebraska at age 98.

Harman, who worked into his mid-90s at the Univ. of Nebraska Medical Center—arriving each day at 7 a.m.—died after a brief illness at a hospital in Omaha, medical center spokesman Tom O’Connor said.

Harvard Medical School professor David Sinclair said Harman’s research inspired thousands of young scientists—including himself—to work on aging research.

“Dr. Harman is one of the most influential scientists of the past 50 years, bringing world-class science to what was once a backwater of biology,” Sinclair said in a statement Tuesday.

Harman developed the “Free Radical Theory of Aging” in 1954, though it took years for additional research to prove its importance. In simple terms, the theory holds that one of the byproducts of oxygen utilization is adverse chemical reactions in cells. The result is aging and, ultimately, death.

The medical community initially scoffed at Harman’s theory. But by the 1980s, free radicals had become part of research into cancer, cardiovascular disease and strokes. Free radicals have since been linked to Alzheimer’s disease.

Sinclair said the theory “is a cornerstone of the aging field.

Harman believed the aging process could be slowed by reducing the production of free radicals with a healthy diet, regular exercise and taking certain vitamins. He also recommended not smoking and limiting drinking alcohol.

He held both medical and doctorate degrees. Although he officially retired in 1986, he worked for more than another decade on his research before again retiring in 2010.

Related Articles Read More >

RED-CRISPR doubles knock-in efficiency
Thermo Fisher adds chemically defined E. coli fermentation medium and feed to Gibco Bacto line
JLL: 2026 could be a realignment year for life science labs
How Prelude and QDX are using quantum chemistry to discover cancer treatments
rd newsletter
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest info on technologies, trends, and strategies in Research & Development.
RD 25 Power Index

R&D World Digital Issues

Fall 2025 issue

Browse the most current issue of R&D World and back issues in an easy to use high quality format. Clip, share and download with the leading R&D magazine today.

R&D 100 Awards
Research & Development World
  • Subscribe to R&D World Magazine
  • Sign up for R&D World’s newsletter
  • Contact Us
  • About Us
  • Drug Discovery & Development
  • Pharmaceutical Processing
  • Global Funding Forecast

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search R&D World

  • R&D World Home
  • Topics
    • Aerospace
    • Automotive
    • Biotech
    • Careers
    • Chemistry
    • Environment
    • Energy
    • Life Science
    • Material Science
    • R&D Management
    • Physics
  • Technology
    • 3D Printing
    • A.I./Robotics
    • Software
    • Battery Technology
    • Controlled Environments
      • Cleanrooms
      • Graphene
      • Lasers
      • Regulations/Standards
      • Sensors
    • Imaging
    • Nanotechnology
    • Scientific Computing
      • Big Data
      • HPC/Supercomputing
      • Informatics
      • Security
    • Semiconductors
  • R&D Market Pulse
  • R&D 100
    • 2025 R&D 100 Award Winners
    • 2025 Professional Award Winners
    • 2025 Special Recognition Winners
    • R&D 100 Awards Event
    • R&D 100 Submissions
    • Winner Archive
  • Resources
    • Research Reports
    • Digital Issues
    • Educational Assets
    • R&D Index
    • Subscribe
    • Video
    • Webinars
    • Content submission guidelines for R&D World
  • Global Funding Forecast
  • Top Labs
  • Advertise
  • SUBSCRIBE